Zobrazeno 1 - 10
of 142
pro vyhledávání: '"ALK rearrangement-positive NSCLC"'
Autor:
Okawa, Sachi1, Shibayama, Takuo1 shibayamat@okayamamc.jp, Shimonishi, Atsushi1, Nishimura, Jun1, Ozeki, Taichi1, Takada, Kenji1, Kayatani, Hiroe1, Minami, Daisuke1, Sato, Ken1, Fujiwara, Keiichi1, Yonei, Toshiro1, Sato, Toshio1, Suno, Manabu2
Publikováno v:
Case Reports in Oncology. Sep-Dec2018, Vol. 11 Issue 3, p777-783. 7p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sachi Okawa, Takuo Shibayama, Atsushi Shimonishi, Jun Nishimura, Taichi Ozeki, Kenji Takada, Hiroe Kayatani, Daisuke Minami, Ken Sato, Keiichi Fujiwara, Toshiro Yonei, Toshio Sato, Manabu Suno
Publikováno v:
Case Reports in Oncology, Vol 11, Iss 3, Pp 777-783 (2018)
Although crizotinib shows marked antitumor activity in anaplastic lymphoma kinase (ALK) rearrangement-positive non-small-cell lung cancer (NSCLC) patients, all treated patients ultimately develop resistance to this drug. Isolated central nervous syst
Externí odkaz:
https://doaj.org/article/a2b942ddf8934043b55665371f598498
Autor:
Kenji Takada, Takuo Shibayama, Hiroe Kayatani, Sachi Okawa, Ken Sato, Toshiro Yonei, Daisuke Minami, Jun Nishimura, Toshio Sato, Manabu Suno, Atsushi Shimonishi, Keiichi Fujiwara, Taichi Ozeki
Publikováno v:
Case Reports in Oncology, Vol 11, Iss 3, Pp 777-783 (2018)
Case Reports in Oncology
Case Reports in Oncology
Although crizotinib shows marked antitumor activity in anaplastic lymphoma kinase (ALK) rearrangement-positive non-small-cell lung cancer (NSCLC) patients, all treated patients ultimately develop resistance to this drug. Isolated central nervous syst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ace2cb45abab66b3bdb52a3d1e4ded2f
https://www.karger.com/Article/FullText/492150
https://www.karger.com/Article/FullText/492150
Autor:
Liao, Bin-Chi1,2,3 (AUTHOR), Chiang, Nai-Jung4,5,6 (AUTHOR), Chang, Gee-Chen7 (AUTHOR), Su, Wu-Chou8 (AUTHOR), Luo, Yung-Hung9 (AUTHOR), Chong, Inn-Wen10 (AUTHOR), Yang, Tsung-Ying11 (AUTHOR), Lai, Chun-Liang12,13 (AUTHOR), Hsia, Te-Chun14 (AUTHOR), Ho, Ching-Liang15 (AUTHOR), Lee, Kang-Yun16 (AUTHOR), Hsiao, Chin-Fu17 (AUTHOR), Ku, Fan-Chen18 (AUTHOR), Fang, Wei-Tse19 (AUTHOR), Chih-Hsin Yang, James1,2,3 (AUTHOR) chihyang@ntu.edu.tw
Publikováno v:
JCO Global Oncology. 12/1/2024, Vol. 10, p1-10. 10p.
Autor:
Oya, Yuko1 (AUTHOR), Yoshida, Tatsuya1 (AUTHOR) t.yoshida@aichi-cc.jp, Uemura, Takehiro1 (AUTHOR), Murakami, Yoshiko2 (AUTHOR), Inaba, Yoshitaka3 (AUTHOR), Hida, Toyoaki1 (AUTHOR)
Publikováno v:
Oncology Letters. Oct2018, Vol. 16 Issue 4, p4219-4222. 4p. 1 Color Photograph, 1 Black and White Photograph, 1 Graph.
Autor:
Fukuda, Akito, Yoshida, Tatsuya
Publikováno v:
Expert Review of Anticancer Therapy; 2023, Vol. 23 Issue 11, p1157-1167, 11p
Autor:
MUSHI, ROSEMARY T.1, YUMEI YANG2, QIAN CAI1, RUIGUANG ZHANG1, GANG WU1, XIAORONG DONG1 hustwhuh@126.com
Publikováno v:
Oncology Letters. Dec2016, Vol. 12 Issue 6, p4361-4366. 6p.
Autor:
Eiji Iwama1,2, Isamu Okamoto3 okamotoi@kokyu.med.kyushu-u.ac.jp, Taishi Harada2, Koichi Takayama2, Yoichi Nakanishi2,3
Publikováno v:
OncoTargets & Therapy. 2014, Vol. 7, p375-385. 11p.
Autor:
Yamaguchi, Teppei1 (AUTHOR) yteppei@aichi-cc.jp, Shimizu, Junichi1 (AUTHOR), Matsuzawa, Reiko1 (AUTHOR), Watanabe, Naohiro1 (AUTHOR), Horio, Yoshitsugu1 (AUTHOR), Fujiwara, Yutaka1 (AUTHOR)
Publikováno v:
BMC Cancer. 7/15/2024, Vol. 24 Issue 1, p1-10. 10p.